OPHTHOCHLOR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ophthochlor, and what generic alternatives are available?
Ophthochlor is a drug marketed by Parkedale and is included in one NDA.
The generic ingredient in OPHTHOCHLOR is chloramphenicol. There are fourteen drug master file entries for this compound. Additional details are available on the chloramphenicol profile page.
Summary for OPHTHOCHLOR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 122 |
Patent Applications: | 6,970 |
Formulation / Manufacturing: | see details |
DailyMed Link: | OPHTHOCHLOR at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for OPHTHOCHLOR
US Patents and Regulatory Information for OPHTHOCHLOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Parkedale | OPHTHOCHLOR | chloramphenicol | SOLUTION/DROPS;OPHTHALMIC | 061220-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |